Christina Ha MD (@tinahamd) 's Twitter Profile
Christina Ha MD

@tinahamd

Inflammatory Bowel Disease, Mayo Clinic Arizona

ID: 988512622667415558

calendar_today23-04-2018 20:19:09

1,1K Tweet

2,2K Followers

122 Following

CGH (@aga_cgh) 's Twitter Profile Photo

Patients with #IBD and a history of cancer who have been treated with various immunosuppressive medications were found to have no greater risk of developing recurrent or new cancers compared to patients with IBD who were not exposed to these medications: ow.ly/2qZV50VmpQi

Patients with #IBD and a history of cancer who have been treated with various immunosuppressive medications were found to have no greater risk of developing recurrent or new cancers compared to patients with IBD who were not exposed to these medications: ow.ly/2qZV50VmpQi
Dr Mark Silverberg (@guthealthmd) 's Twitter Profile Photo

Informative talk by a persistent and great scientist and great person. Leading the way to make progress in fibrostenotic CD. Florian Rieder with some touching moments during his talk about his mentors and family. He is already a mentor to many junior folks!

Informative talk by a persistent and great scientist and great person.  Leading the way to make progress in fibrostenotic CD. <a href="/IBD_FloMD/">Florian Rieder</a> with some touching moments during his talk about his mentors and family. He is already a mentor to many junior folks!
@IBDConference (@ibdconference) 's Twitter Profile Photo

Nashville, TN | April 5–6 #AIBDRegionals kicks off THIS WEEKEND! Join top #IBD experts for high-impact, practical IBD education you can apply Monday morning. CME credits, networking, and game-changing insights await. Register now: hubs.ly/Q03fqjFg0

Nashville, TN | April 5–6
#AIBDRegionals kicks off THIS WEEKEND!
Join top #IBD experts for high-impact, practical IBD education you can apply Monday morning.
CME credits, networking, and game-changing insights await.
Register now: hubs.ly/Q03fqjFg0
Dominik Bettenworth (@bettenworthdb) 's Twitter Profile Photo

What sets Florian Rieder apart, isn’t just being one of the most knowledgeable individuals in intestinal fibrosis and one of the hardest working #IBD-ologist - it’s also his genuine support, integrity, and lasting friendship. #TrueLeader

Meena Bewtra (@drsmeena) 's Twitter Profile Photo

This is so important for patients & providers AND clinical trials: having to wait for a "washout" from a biologic to start a new one can delay important treatment. We showed NO ⬆️ infection risk if skipping that washout. Honored to work w/these co-authors #StandUpForScience

@IBDConference (@ibdconference) 's Twitter Profile Photo

Join us June 21-22 for #AIBDRegionals event & get the latest updates on #IBD therapies, case-based learning, & expert insights. Don’t miss this chance to network with local peers and advance your practice. Register today! hmpglobalevents.com/aibdregionals/… Raymond Cross Christina Ha MD

Siew Ng (@siew_c_ng) 's Twitter Profile Photo

Over a decade since I collaborated with world-class epidemiologist Gil Kaplan MD MPH and his team, here is our long awaited paper out in nature reporting for the first time evolution of #ibd across 4 stages Helmsley Charitable Trust IOIBD CUHK Medicine GIVES-21 nature.com/articles/s4158…

Crohn's & Colitis Foundation (@crohnscolitisfn) 's Twitter Profile Photo

Crohn’s & Colitis Foundation investigators are back at #DDW2025! Check out Foundation supported research being presented at 10+ main scientific sessions throughout the busy 3 days of #DDW2025.

Crohn’s &amp; Colitis Foundation investigators are back at #DDW2025! Check out Foundation supported research being presented at 10+ main scientific sessions throughout the busy 3 days of #DDW2025.
Charlie Lees (@charlie_lees) 's Twitter Profile Photo

Early data on AGMB-129 - a novel treatment for firbrostenosing Crohn’s disease Very encouraging interim analysis from phase 2a trial Congratulations Florian Rieder - standout trial from #DDW2025

Early data on AGMB-129 - a novel treatment for firbrostenosing Crohn’s disease

Very encouraging interim analysis from phase 2a trial  

Congratulations <a href="/IBD_FloMD/">Florian Rieder</a> - standout trial from #DDW2025
Florian Rieder (@ibd_flomd) 's Twitter Profile Photo

Digestive Disease Week #DDW2025 #STARConsortium Industry Board Meeting. Tremendous progress by the team with the first trial #Agomab @STENOVA on the way with encouraging interim results. Onwards and upwards through industry with academia collaboration... Christina Ha MD Miguel Regueiro Vipul Jairath MBChB DPhil

<a href="/DDWMeeting/">Digestive Disease Week</a> #DDW2025 #STARConsortium Industry Board Meeting. Tremendous progress by the team with the first trial #Agomab @STENOVA on the way with encouraging interim results. Onwards and upwards through industry with academia collaboration... <a href="/tinahamd/">Christina Ha MD</a> <a href="/MRegueiroMD/">Miguel Regueiro</a> <a href="/vipuljairath/">Vipul Jairath MBChB DPhil</a>
Meena Bewtra (@drsmeena) 's Twitter Profile Photo

If you're a fellow considering IBD, or if you are a GI PD with trainees or APPs, there is absolutely no better program than MilestoneIBD: it both teaches & establishes lifelong connections. Fellow & APP application open! Also, kudos to Florian Rieder amazing group-selfie skills!

Charlie Lees (@charlie_lees) 's Twitter Profile Photo

World IBD Day: a call to arms I’m asking our global IBD community—patients, clinicians, researchers, industry, tech and policy-makers—to rally around three clear goals. 1️⃣ Implement what already works — everywhere We have the tools; we’re just not using them universally. •

Vipul Jairath MBChB DPhil (@vipuljairath) 's Twitter Profile Photo

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by ⁦Christopher Ma MD MPH⁩ with global contributions! pubmed.ncbi.nlm.nih.gov/40446946/

Edward Barnes MD MPH (@edbarnesmd) 's Twitter Profile Photo

I believe there's an opportunity to re-evaluate our approach to patients after #IPAA for #UC. #HansHerfarth and I discuss moving from a reactive ➡️ proactive approach in CGH UNC Gastroenterology cghjournal.org/article/S1542-…

I believe there's an opportunity to re-evaluate our approach to patients after #IPAA for #UC. 

#HansHerfarth and I discuss moving from a reactive ➡️ proactive approach in <a href="/AGA_CGH/">CGH</a> <a href="/UNCGastro/">UNC Gastroenterology</a>  

cghjournal.org/article/S1542-…